Usha, Veeraraghavan, Dover, Lynn G., Roper, David L. and Besra, Gurdyal S.. (2008) Characterization of Mycobacterium tuberculosis diaminopimelic acid epimerase: paired cysteine residues are crucial for racemization. FEMS Microbiology Letters, Vol.280 (No.1). pp. 57-63. ISSN 0378-1097

Full text not available from this repository.

Abstract

Recently, the overproduction of Mycobacterium tuberculosis diaminopimelic acid (DAP) epimerase MtDapF in Escherichia coli using a novel codon alteration cloning strategy and the characterization of the purified enzyme was reported. In the present study, the effect of sulphydryl alkylating agents on the in vitro activity of M. tuberculosis DapF was tested. The complete inhibition of the enzyme by 2-nitro-5-thiocyanatobenzoate, 5,5'-dithio-bis(2-nitrobenzoic acid) and 1,2-benzisothiazolidine-3-one at nanomolar concentrations suggested that these sulphydryl alkylating agents modify functionally significant cysteine residues at or near the active site of the epimerase. Consequently, the authors extended the characterization of MtDapF by studying the role of the two strictly conserved cysteine residues. The putative catalytic residues Cys87 and Cys226 of MtDapF were replaced individually with both serine and alanine. Residual epimerase activity was detected for both the serine replacement mutants C87S and C226S in vitro. Kinetic analyses revealed that, despite a decrease in the K-M value of the C87S mutant for DAP that presumably indicates an increase in nonproductive substrate binding, the catalytic efficiency of both serine substitution mutants was severely compromised. When either C87 or C226 were substituted with alanine, epimerase activity was not detected emphasizing the importance of both of these cysteine residues in catalysis.

Item Type:	Journal Article
Subjects:	Q Science > QP Physiology Q Science > QR Microbiology
Divisions:	Faculty of Science > Life Sciences (2010- )
Library of Congress Subject Headings (LCSH):	Mycobacterium tuberculosis, Peptidoglycans, Isomerases, Cysteine proteinases, Racemization
Journal or Publication Title:	FEMS Microbiology Letters
Publisher:	Wiley-Blackwell Publishing Ltd.
ISSN:	0378-1097
Date:	March 2008
Volume:	Vol.280
Number:	No.1
Number of Pages:	7
Page Range:	pp. 57-63
Identification Number:	10.1111/j.1574-6968.2007.01049.x
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Funder:	The Darwin Trust of Edinburgh, Royal Society (Great Britain), Wellcome Trust (London, England), Medical Research Council (Great Britain) (MRC)
References:	Ashiuchi M, Tani K, Soda K & Misono H (1998) Properties of glutamate racemase from Bacillus subtilis IFO 3336 producing poly-gamma-glutamate. J Biochem (Tokyo) 123: 1156–1163. Banerjee A, Dubnau E, Quemard A et al. (1994) InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227–230. Barreto ML, Pereira SM & Ferreira AA (2006) BCG vaccine: efficacy and indications for vaccination and revaccination. J Pediatr (Rio J) 82: S45–S54. Bhatt A, Fujiwara N, Bhatt K et al. (2007) Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci USA 104: 5157–5162. Born TL & Blanchard JS (1999) Structure/function studies on enzymes in the diaminopimelate pathway of bacterial cell wall biosynthesis. Curr Opin Chem Biol 3: 607–613. C´aceres NE, Harris NB, Wellehan JF, Feng Z, Kapur V & Barletta RG (1997) Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J Bacteriol 179: 5046–5055. Chambers HF, Moreau D, Yajko D et al. (1995) Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother 39: 2620–2624. Cirilli M, Zheng R, Scapin G & Blanchard JS (1998) Structural symmetry: the three-dimensional structure of Haemophilus influenzae diaminopimelate epimerase. Biochemistry 37: 16452–16458. Dye C (2006) Global epidemiology of tuberculosis. Lancet 367: 938–940. Gallo KA & Knowles JR (1993) Purification, cloning, and cofactor independence of glutamate racemase from Lactobacillus. Biochemistry 32: 3981–3990. Gao LY, Laval F, Lawson EH et al. (2003) Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol Microbiol 49: 1547–1563. Glavas S & Tanner ME (1999) Catalytic acid/base residues of glutamate racemase. Biochemistry 38: 4106–4113. Goffin C & Ghuysen JM (2002) Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol Mol Biol Rev 66: 702–738. Hartmann M, Tauch A, Eggeling L, Bathe B, Mockel B, Puhler A & Kalinowski J (2003) Identification and characterization of the last two unknown genes, dapC and dapF, in the succinylase branch of the L-lysine biosynthesis of Corynebacterium glutamicum. J Biotechnol 104: 199–211. HigginsW, Tardif C, Richaud C, Krivanek MA & Cardin A (1989) Expression of recombinant diaminopimelate epimerase in Escherichia coli. Isolation and inhibition with an irreversible inhibitor. Eur J Biochem 186: 137–143. Kaufmann SH & Parida SK (2007) Changing funding patterns in tuberculosis. Nat Med 13: 299–303. Koo CW & Blanchard JS (1999) Chemical mechanism of Haemophilus influenzae diaminopimelate epimerase. Biochemistry 38: 4416–4422. Koo CW, Sutherland A, Vederas JC & Blanchard JS (2000) Identification of active site cysteine residues that function as general bases: diaminopimelate epimerase. J Am Chem Soc 122: 6122–6123. Kremer L, Dover LG, Morbidoni HR et al. (2003) Inhibition of inhA activity, but not kasA activity, induces formation of a kasA-containing complex in mycobacteria. J Biol Chem 278: 20547–20554. Lloyd AJ, Huyton T, Turkenburg J & Roper DI (2004) Refinement of Haemophilus influenzae diaminopimelic acid epimerase (dapF) at 1.75 A resolution suggests a mechanism for stereocontrol during catalysis. Acta Crystallogr D Biol Crystallogr 60: 397–400. Pillai B, Cherney MM, Diaper CM, Sutherland A, Blanchard JS, Vederas JC & James MN (2006) Structural insights into stereochemical inversion by diaminopimelate epimerase: an antibacterial drug target. Proc Natl Acad Sci USA 103: 8668–8673. Richaud C, Higgins W, Mengin-Lecreulx D & Stragier P (1987) Molecular cloning, characterization, and chromosomal localization of dapF, the Escherichia coli gene for diaminopimelate epimerase. J Bacteriol 169: 1454–1459. Rudnick G & Abeles RH (1975) Reaction mechanism and structure of the active site of proline racemase. Biochemistry 14: 4515–4522. Ruiz RC (1964) D-cycloserine in the treatment of pulmonary tuberculosis resistant to the standard drugs: a study of 116 cases. Dis Chest 45: 181–186. Schleifer KH & Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407–477. Takayama K & Kilburn JO (1989) Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 33: 1493–1499. Tanner ME (2002) Understanding nature’s strategies for enzymecatalyzed racemization and epimerization. Acc Chem Res 35: 237–246. Tanner ME, Gallo KA & Knowles JR (1993) Isotope effects and the identification of catalytic residues in the reaction catalyzed by glutamate racemase. Biochemistry 32: 3998–4006. Usha V, Dover LG, Roper DL, Lloyd AJ & Besra GS (2006) Use of a codon alteration strategy in a novel approach to cloning the Mycobacterium tuberculosis diaminopimelic acid epimerase. FEMS Microbiol Lett 262: 39–47. Vilcheze C, Wang F, Arai M et al. (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12: 1027–1029. Wietzerbin J, Das BC, Petit JF, Lederer E, Leyh-Bouille M & Ghuysen JM (1974) Occurrence of D-alanyl-(D)-mesodiaminopimelic acid and meso-diaminopimelyl-mesodiaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry 13: 3471–3476. Winder FGA, Collins P & Rooney SA (1970) Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope. Biochem J 117: P27. Wiseman JS & Nichols JS (1984) Purification and properties of diaminopimelic acid epimerase from Escherichia coli. J Biol Chem 259: 8907–8914.
URI:	http://wrap.warwick.ac.uk/id/eprint/30629

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item